ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Cancer
Phase 2a UTOPIA-1 trial results showed Trichomylin® softgel capsules demonstrated clinically relevant efficacy signals using multiple pain assessments. Trichomylin® softgel capsules were well-tolerated, with no related serious adverse events observed, supporting the sustainability of an...